Page last updated: 2024-10-17

bupropion and Labhart-Willi Syndrome

bupropion has been researched along with Labhart-Willi Syndrome in 2 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Research Excerpts

ExcerptRelevanceReference
"The aim of this article is to review related literature on management of hyperphagia and impulsive behaviors in Prader-Willi syndrome (PWS) that includes either naltrexone or bupropion."4.93Prader-Willi Syndrome, Management of Impulsivity, and Hyperphagia in an Adolescent. ( Malik, S; Ogden, S; Puri, MR; Sahl, R, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Puri, MR1
Sahl, R1
Ogden, S1
Malik, S1
Hor, A1
Purtell, L1

Reviews

1 review available for bupropion and Labhart-Willi Syndrome

ArticleYear
Prader-Willi Syndrome, Management of Impulsivity, and Hyperphagia in an Adolescent.
    Journal of child and adolescent psychopharmacology, 2016, Volume: 26, Issue:4

    Topics: Adolescent; Anti-Obesity Agents; Bupropion; Drug Combinations; Female; Humans; Hyperphagia; Impulsiv

2016

Other Studies

1 other study available for bupropion and Labhart-Willi Syndrome

ArticleYear
Influence of Naltrexone/Bupropion Combination Treatment on Body Mass Index in Prader-Willi Syndrome Re: "Prader-Willi Syndrome, Management of Impulsivity, and Hyperphagia in an Adolescent" by Puri et al.
    Journal of child and adolescent psychopharmacology, 2016, Volume: 26, Issue:9

    Topics: Adolescent; Body Mass Index; Bupropion; Humans; Hyperphagia; Impulsive Behavior; Naltrexone; Prader-

2016